ERADIAS: Evaluation of the Structure Modifying Effect of Avocado-Soybean Unsaponifiables in Hip Osteoarthritis

Sponsor
Laboratoires Expanscience S.A. (Industry)
Overall Status
Completed
CT.gov ID
NCT01062737
Collaborator
(none)
1
1
81

Study Details

Study Description

Brief Summary

This study aims to assess the long term (three years) ability of ASU (Avocado Soya unsaponifiable) to slow the decrease of radiographic JSW (Joint Space Width) in hip osteoarthritis (OA). This is a randomized, double blind, comparative, parallel group study versus placebo.

Condition or Disease Intervention/Treatment Phase
Phase 3

Detailed Description

Inclusion criteria:

Primary hip OA, fulfilling ACR criteria, patient over 45 y, painful > 1 year, Lequesne's index > or equal to 3, with minimum JSW at the target hip > 1 mm and < 4 mm on pelvic radiograph.

Primary criterion of efficacy:

The main criterion of efficacy is the change of JSW between baseline and end point. JSW is measured on the narrowest joint on pelvic or target hip X ray by blinded reader.

Randomisation is stratified according JSW at baseline (< 2,5 mm or > or equal to 2,5 mm).

Statistical analysis:

The Full Analysis Set (FAS) is defined by patients with at least one baseline value and one post baseline value.

The main analysis is scheduled on FAS using a Missing At Random (MAR)with a multiple model repeated measure (MMRM)to take in account missing value.

SAP (Statistical Analysis Plan) schedule to analyse JSW change as quantitative variable using an ANCOVA and as qualitative variable (progressors defined as JSW loss upper than 0,5 mm) using Mantel Haentzel test.

Study Design

Study Type:
Interventional
Official Title:
Evaluation of the Structure-modifying Effect and Safety of Avocado-Soybean Unsaponifiable (Piascledine 300) in Hip Osteoarthritis (OA) a 3 Years Multicenter Randomized, Double Blind, Placebo Controlled Trial
Study Start Date :
Dec 1, 1999
Actual Primary Completion Date :
Sep 1, 2006
Actual Study Completion Date :
Sep 1, 2006

Arms and Interventions

Arm Intervention/Treatment
Experimental: ASU (Avocado Soybean Unsaponifiable)

Drug: ASU

Outcome Measures

Primary Outcome Measures

  1. The main criterion of efficacy is the change of JSW between baseline and end point. JSW is measured on the narrowest joint on pelvic or target hip X ray by blinded reader. []

Eligibility Criteria

Criteria

Ages Eligible for Study:
45 Years to 75 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • primary OA of hip,

  • ACR criteria,

  • older than 45 years,

  • symptomatic painful > 1 an,

  • Lequesne's index > or equal to 3,

  • JSW between 1 and 4 mm on pelvic radiograph.

Exclusion Criteria:
  • secondary OA.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Multiple locations Paris France

Sponsors and Collaborators

  • Laboratoires Expanscience S.A.

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
, ,
ClinicalTrials.gov Identifier:
NCT01062737
Other Study ID Numbers:
  • PR 2898
First Posted:
Feb 4, 2010
Last Update Posted:
Feb 4, 2010
Last Verified:
Feb 1, 2010
Additional relevant MeSH terms:

Study Results

No Results Posted as of Feb 4, 2010